Patents by Inventor Lance Palmer
Lance Palmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210214810Abstract: The present disclosure relates to oligonucleotide sequences for amplification primers and their use in performing nucleic acid amplifications of HCV, in particular regions that encode the NS3 polypeptide. In some embodiments the primers are used in nested PCR methods for the detection or sequencing of HCV NS3. The oligonucleotide sequences are also provided assembled as kits that can be used to amplify and detect or sequence HCV NS3.Type: ApplicationFiled: March 17, 2021Publication date: July 15, 2021Applicant: Siemens Healthcare Diagnostics Inc.Inventors: Arejas Uzgiris, Sunil Pandit, Lance Palmer
-
Patent number: 10982294Abstract: The present disclosure relates to oligonucleotide sequences for amplification primers and their use in performing nucleic acid amplifications of HCV, in particular regions that encode the NS3 polypeptide. In some embodiments the primers are used in nested PCR methods for the detection or sequencing of HCV NS3. The oligonucleotide sequences are also provided assembled as kits that can be used to amplify and detect or sequence HCV NS3.Type: GrantFiled: December 1, 2016Date of Patent: April 20, 2021Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Arejas Uzgiris, Sunil Pandit, Lance Palmer
-
Patent number: 10851428Abstract: The present invention is based in part on the present inventors' appreciation that certain sequences within an HIV genome are more likely to successfully detect HIV across a breadth of HIV variants. The ability to detect and/or quantify the presence and/or load of HIV in a subject is important to, among other things, the diagnosis and treatment of infected individuals. The present invention is based, in part, on the discovery of oligonucleotide reagents that detectably amplify sequences from a greater breadth of HIV samples than certain prior reagents and/or that generate amplicons from HIV genomes from which certain prior reagents would not have generated amplicons. Oligonucleotide reagents as described herein provide unexpected benefits in the detection and/or quantification of the presence and/or load of HIV in a subject, and thereby in the diagnosis and treatment of HIV.Type: GrantFiled: September 16, 2016Date of Patent: December 1, 2020Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Sunil Pandit, Arejas Uzgiris, Lance Palmer
-
Publication number: 20180245166Abstract: The present invention is based in part on the present inventors' appreciation that certain sequences within an HIV genome are more likely to successfully detect HIV across a breadth of HIV variants. The ability to detect and/or quantify the presence and/or load of HIV in a subject is important to, among other things, the diagnosis and treatment of infected individuals. The present invention is based, in part, on the discovery of oligonucleotide reagents that detectably amplify sequences from a greater breadth of HIV samples than certain prior reagents and/or that generate amplicons from HIV genomes from which certain prior reagents would not have generated amplicons. Oligonucleotide reagents as described herein provide unexpected benefits in the detection and/or quantification of the presence and/or load of HIV in a subject, and thereby in the diagnosis and treatment of HIV.Type: ApplicationFiled: September 16, 2016Publication date: August 30, 2018Applicant: Siemens Healthcare Diagnostics Inc.Inventors: Sunil Pandit, Arejas Uzgiris, Lance Palmer
-
Publication number: 20170137901Abstract: The present disclosure relates to oligonucleotide sequences for amplification primers and their use in performing nucleic acid amplifications of HCV, in particular regions that encode the NS3 polypeptide. In some embodiments the primers are used in nested PCR methods for the detection or sequencing of HCV NS3. The oligonucleotide sequences are also provided assembled as kits that can be used to amplify and detect or sequence HCV NS3.Type: ApplicationFiled: December 1, 2016Publication date: May 18, 2017Applicant: Siemens Healthcare Diagnostics Inc.Inventors: Arejas Uzgiris, Sunil Pandit, Lance Palmer
-
Patent number: 9528163Abstract: The present disclosure relates to oligonucleotide sequences for amplification primers and their use in performing nucleic acid amplifications of HCV, in particular regions that encode the NS3 polypeptide. In some embodiments the primers are used in nested PCR methods for the detection or sequencing of HCV NS3. The oligonucleotide sequences are also provided assembled as kits that can be used to amplify and detect or sequence HCV NS3.Type: GrantFiled: June 20, 2012Date of Patent: December 27, 2016Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Arejas Uzgiris, Sunil Pandit, Lance Palmer
-
Publication number: 20150299814Abstract: The present disclosure relates to oligonucleotide sequences for amplification primers and their use in performing nucleic acid amplifications of HIV, in particular regions that encode the V3 region of the env glycoprotein. In some embodiments the primers are used in nested PCR methods for the detection or sequencing of the V3 region of the env glycoprotein. The oligonucleotide sequences are also provided assembled as kits that can be used to detect or sequence the V3 region of the env glycoprotein. Control nucleic acids for use in methods and kits of the present disclosure are also provided.Type: ApplicationFiled: October 10, 2013Publication date: October 22, 2015Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.Inventors: Arejas UZGIRIS, Sunil PANDIT, Lance PALMER
-
Publication number: 20140134605Abstract: The present disclosure relates to oligonucleotide sequences for amplification primers and their use in performing nucleic acid amplifications of HCV, in particular regions that encode the NS3 polypeptide. In some embodiments the primers are used in nested PCR methods for the detection or sequencing of HCV NS3. The oligonucleotide sequences are also provided assembled as kits that can be used to amplify and detect or sequence HCV NS3.Type: ApplicationFiled: June 20, 2012Publication date: May 15, 2014Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.Inventors: Arejas Uzgiris, Sunil Pandit, Lance Palmer
-
Patent number: 8446040Abstract: A system and method for adaptive control of power among a plurality of loads based on a categorization of the loads as either delayable or non-delayable, wherein the non-delayable loads are preferably supplied power over the delayable loads. In one aspect, the system may be used to allocate limited power from a backup power source.Type: GrantFiled: August 30, 2010Date of Patent: May 21, 2013Assignee: Scheider Electric IT CorporationInventors: Nam Wook Paik, Lance Palmer Haines, Vishwas Mohaniraj Deokar, James H. Donalds, Michael Manganese
-
Publication number: 20110049980Abstract: A system and method for adaptive control of power among a plurality of loads based on a categorization of the loads as either delayable or non-delayable, wherein the non-delayable loads are preferably supplied power over the delayable loads. In one aspect, the system may be used to allocate limited power from a backup power source.Type: ApplicationFiled: August 30, 2010Publication date: March 3, 2011Applicant: AMERICAN POWER CONVERSION CORPORATIONInventors: Nam Wook Paik, Lance Palmer Haines, Vishwas Mohaniraj Deokar, James H. Donalds, Michael Manganese
-
Patent number: 7786617Abstract: A system and method for adaptive control of power among a plurality of loads based on a categorization of the loads as either delayable or non-delayable, wherein the non-delayable loads are preferably supplied power over the delayable loads. In one aspect, the system may be used to allocate limited power from a backup power source.Type: GrantFiled: January 15, 2009Date of Patent: August 31, 2010Assignee: American Power Conversion CorporationInventors: Nam Wook Paik, Lance Palmer Haines, Vishwas Mohaniraj Deokar, James H. Donalds, Michael Manganese
-
Publication number: 20090121547Abstract: A system and method for adaptive control of power among a plurality of loads based on a categorization of the loads as either delayable or non-delayable, wherein the non-delayable loads are preferably supplied power over the delayable loads. In one aspect, the system may be used to allocate limited power from a backup power source.Type: ApplicationFiled: January 15, 2009Publication date: May 14, 2009Applicant: AMERICAN POWER CONVERSION CORPORATIONInventors: Nam Wook Paik, Lance Palmer Haines, Vishwas Mohaniraj Deokar, James H. Donalds, Michael Manganese
-
Patent number: 7514815Abstract: A system and method for adaptive control of power among a plurality of loads based on a categorization of the loads as either delayable or non-delayable, wherein the non-delayable loads are preferably supplied power over the delayable loads. In one aspect, the system may be used to allocate limited power from a backup power source.Type: GrantFiled: September 28, 2004Date of Patent: April 7, 2009Assignee: American Power Conversion CorporationInventors: Nam Wook Paik, Lance Palmer Haines, Vishwas Mohaniraj Deokar, James H. Donalds, Michael Manganese